Medifast, Inc. Announces Second Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Medifast (MED) Tops Q2 EPS by 3c, Revenues Beat; Raises FY19 EPS/Revenue Guidance
August 1, 2019 5:51 PM EDTMedifast (NYSE: MED) reported Q2 EPS of $1.75, $0.03 better than the analyst estimate of $1.72. Revenue for the quarter came in at $187.1 million versus the consensus estimate of $182.26 million.
Record revenue up 59.5% to $187.1 millionNet income up 51.3% to $21.4 million55.3% growth in active earning OPTAVIA Coaches to 30,600Earnings per diluted share ("EPS") of $1.75, an increase of 50.9%"These record results are another demonstration of Medifast's continued commitment to delivering sustainable growth through our mission to offer the... More
